Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2?

The study aimed to describe patient characteristics and outcomes by PaO2/FiO2 (PAFI) and degree of inflammation. Retrospective cohort study with data on patients collected from March 1st, 2020 to March 1st, 2023, from the Spanish SEMI-COVID-19 Registry. Non-nosocomial patients with data on PAFI (300...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revista clínica espanõla (English edition) 2025-02, Vol.225 (2), p.57-69
Hauptverfasser:	Rubio-Rivas, M., Mora-Luján, J.M., Montero Sáez, A., Martín-Escalante, M.D., Giner Galvañ, V., Maestro de la Calle, G., Taboada Martínez, M.L., Muiño Míguez, A., Lumbreras-Bermejo, C., Antón-Santos, J.-M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Biomarkers - blood Cohort Studies COVID-19 COVID-19 - diagnosis COVID-19 - mortality Female Hospital Mortality Humans Inflamación Inflammation Male Middle Aged Mortalidad Mortality PaO2/FiO2 Prognosis Pronóstico Retrospective Studies Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!